Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2313335
Max Phase: Preclinical
Molecular Formula: C37H39N7O12
Molecular Weight: 773.76
Molecule Type: Small molecule
Associated Items:
ID: ALA2313335
Max Phase: Preclinical
Molecular Formula: C37H39N7O12
Molecular Weight: 773.76
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: [N-]=[N+]=NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)nn3)[C@H]2O)[C@H](O)[C@H]1N1C(=O)c2ccccc2C1=O
Standard InChI: InChI=1S/C37H39N7O12/c38-41-39-15-6-16-52-36-29(44-34(50)23-9-4-5-10-24(23)35(44)51)31(48)33(27(19-46)55-36)56-37-32(49)28(30(47)26(18-45)54-37)43-17-25(40-42-43)20-11-13-22(14-12-20)53-21-7-2-1-3-8-21/h1-5,7-14,17,26-33,36-37,45-49H,6,15-16,18-19H2/t26-,27-,28+,29-,30+,31-,32-,33-,36-,37+/m1/s1
Standard InChI Key: CMRMTZCSSSYBBI-ZGYIDIDBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 773.76 | Molecular Weight (Monoisotopic): 773.2657 | AlogP: 1.56 | #Rotatable Bonds: 14 |
Polar Surface Area: 264.15 | Molecular Species: ACID | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: -10.56 | CX Basic pKa: | CX LogP: 1.64 | CX LogD: 1.52 |
Aromatic Rings: 4 | Heavy Atoms: 56 | QED Weighted: 0.04 | Np Likeness Score: 0.28 |
1. van Hattum H, Branderhorst HM, Moret EE, Nilsson UJ, Leffler H, Pieters RJ.. (2013) Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1., 56 (3): [PMID:23281927] [10.1021/jm301677r] |
Source(1):